Contractor Positron opens radioactive-drug plant

Molecular imaging company Positron has opened a 10,000-square-foot cGMP-ready facility in Indiana for manufacturing both radioactive and non-radioactive pharma products and devices. The contract manufacturer, which specializes in nuclear cardiology, plans to focus initially on small batch, radioactive PET products. Positron release

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.